ArticleMolecular therapy. Nucleic acids2024

SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma.

Philip Prathipati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.